Allianz Asset Management
ORKA

Allianz Asset Management’s Oruka Therapeutics ORKA Stock Holding History

Allianz Asset Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
12,000
+4,900
+69% +$326K ﹤0.01% 1866
2026
Q1 		$348K Sell
7,100
-3,200
-31% -$111K ﹤0.01% 1887
2025
Q4 		$312K Buy
+10,300
New +$287K ﹤0.01% 1895

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Allianz Asset Management's ORKA Position: Q2 2026 in Review

Allianz Asset Management increased its Oruka Therapeutics (ORKA) stake by 69% in Q2 2026, buying an estimated $326K and bringing the position to 12,000 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1866.

Allianz Asset Management first reported a position in ORKA in Q4 2025 and has held it in 3 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Allianz Asset Management held 12,000 shares of Oruka Therapeutics worth $1.14M as of Q2 2026.
  • Allianz Asset Management bought 4,900 Oruka Therapeutics shares in Q2 2026, an estimated $326K.
  • Oruka Therapeutics made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1866 holding.
  • Allianz Asset Management first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.